{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:22:21Z","timestamp":1773321741963,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1750-1172-9-4","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T14:01:26Z","timestamp":1389276086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models"],"prefix":"10.1186","volume":"9","author":[{"given":"Jeremiah","family":"Hadwen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Shamim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Mongeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Holcik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faraz","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"695_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, Flynn K, Hendrickson BC, Scholl T, Sirko-Osadsa DA, Allitto BA: Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Gen. 2012, 20: 27-32. 10.1038\/ejhg.2011.134.","journal-title":"Eur J Hum Gen"},{"key":"695_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-6-71","volume":"6","author":"A D\u2019Amico","year":"2011","unstructured":"D\u2019Amico A, Mercuri E, Tiziano FD, Bertini E: Spinal muscular atrophy. Orphanet J Rare Dis. 2011, 6: 71-10.1186\/1750-1172-6-71.","journal-title":"Orphanet J Rare Dis"},{"key":"695_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80: 155-165. 10.1016\/0092-8674(95)90460-3.","journal-title":"Cell"},{"key":"695_CR4","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B: A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA. 1999, 96: 6307-6311. 10.1073\/pnas.96.11.6307.","journal-title":"Proc Natl Acad Sci USA"},{"key":"695_CR5","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, McPherson JD: A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet. 1999, 8: 1177-1183. 10.1093\/hmg\/8.7.1177.","journal-title":"Hum Mol Genet"},{"key":"695_CR6","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1093\/hmg\/ddp352","volume":"18","author":"F Farooq","year":"2009","unstructured":"Farooq F, Balabanian S, Liu X, Holcik M, MacKenzie A: p38 Mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR. Hum Mol Genet. 2009, 18: 4035-4045. 10.1093\/hmg\/ddp352.","journal-title":"Hum Mol Genet"},{"key":"695_CR7","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/hmg\/ddt191","volume":"22","author":"F Farooq","year":"2013","unstructured":"Farooq F, Abadia-Molina F, MacKenzie D, Hadwen J, Shamim F, O\u2019Reilly S, Holcik M, MacKenzie A: Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation. Hum Mol Genet. 2013, 22: 3415-3424. 10.1093\/hmg\/ddt191.","journal-title":"Hum Mol Genet"},{"key":"695_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.mcn.2005.08.016","volume":"30","author":"EM Garry","year":"2005","unstructured":"Garry EM, Delaney A, Blackburn-Munro G, Dickinson T, Moss A, Nakalembe I, Robertson DC, Rosie R, Robberecht P, Mitchell R, Fleetwood-Walker SM: Activation of p38 and p42\/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia. Mol Cell Neurosci. 2005, 30: 523-537. 10.1016\/j.mcn.2005.08.016.","journal-title":"Mol Cell Neurosci"},{"key":"695_CR9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1471-4159.2007.05018.x","volume":"104","author":"TK Monaghan","year":"2008","unstructured":"Monaghan TK, Mackenzie CJ, Plevin R, Lutz EM: PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases. J Neurochem. 2008, 104: 74-88.","journal-title":"J Neurochem"},{"key":"695_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1172\/JCI29562","volume":"117","author":"AM Avila","year":"2007","unstructured":"Avila AM, Burnett BG, Taye AA, Gabanella F, Knight MA, Hartenstein P, Cizman Z, Di Prospero NA, Pellizzoni L, Fischbeck KH, Sumner CJ: Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Invest. 2007, 117: 659-671. 10.1172\/JCI29562.","journal-title":"J Clin Invest"},{"key":"695_CR11","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/hmg\/ddq023","volume":"19","author":"M Riessland","year":"2010","unstructured":"Riessland M, Ackermann B, Forster A, Jakubik M, Hauke J, Garbes L, Fritzsche I, Mende Y, Blumcke I, Hahnen E, Wirth B: SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum Mol Genet. 2010, 19: 1492-1506. 10.1093\/hmg\/ddq023.","journal-title":"Hum Mol Genet"},{"key":"695_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0014-5793(00)02084-6","volume":"483","author":"M Brook","year":"2000","unstructured":"Brook M, Sully G, Clark AR, Saklatvala J: Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Lett. 2000, 483: 57-61. 10.1016\/S0014-5793(00)02084-6.","journal-title":"FEBS Lett"},{"key":"695_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1074\/jbc.274.1.264","volume":"274","author":"JL Dean","year":"1999","unstructured":"Dean JL, Brook M, Clark AR, Saklatvala J: p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem. 1999, 274: 264-269. 10.1074\/jbc.274.1.264.","journal-title":"J Biol Chem"},{"key":"695_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1128\/MCB.23.2.425-436.2003","volume":"23","author":"MA Frevel","year":"2003","unstructured":"Frevel MA, Bakheet T, Silva AM, Hissong JG, Khabar KS, Williams BR: p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol Cell Biol. 2003, 23: 425-436. 10.1128\/MCB.23.2.425-436.2003.","journal-title":"Mol Cell Biol"},{"key":"695_CR15","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.1074\/jbc.M005486200","volume":"276","author":"K Rutault","year":"2001","unstructured":"Rutault K, Hazzalin CA, Mahadevan LC: Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha ) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts. J Biol Chem. 2001, 276: 6666-6674. 10.1074\/jbc.M005486200.","journal-title":"J Biol Chem"},{"key":"695_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s000110050499","volume":"48","author":"SW Wang","year":"1999","unstructured":"Wang SW, Pawlowski J, Wathen ST, Kinney SD, Lichenstein HS, Manthey CL: Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflamm Res. 1999, 48: 533-538. 10.1007\/s000110050499.","journal-title":"Inflamm Res"},{"key":"695_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0006-8993(00)03228-5","volume":"892","author":"JJ Legos","year":"2001","unstructured":"Legos JJ, Erhardt JA, White RF, Lenhard SC, Chandra S, Parsons AA, Tuma RF, Barone FC: SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Res 2001, 892: 70-77. 10.1016\/S0006-8993(00)03228-5.","journal-title":"Brain Res"},{"key":"695_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/hmg\/ddi078","volume":"14","author":"TT Le","year":"2005","unstructured":"Le TT, Pham LT, Butchbach ME, Zhang HL, Monani UR, Coovert DD, Gavrilina TO, Xing L, Bassell GJ, Burghes AH: SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet. 2005, 14: 845-857. 10.1093\/hmg\/ddi078.","journal-title":"Hum Mol Genet"},{"key":"695_CR19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/cne.20934","volume":"496","author":"M Basille","year":"2006","unstructured":"Basille M, Cartier D, Vaudry D, Lihrmann I, Fournier A, Freger P, Gallo-Payet N, Vaudry H, Gonzalez B: Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development. J Comp Neurol. 2006, 496: 468-478. 10.1002\/cne.20934.","journal-title":"J Comp Neurol"},{"key":"695_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1210\/en.2003-1058","volume":"145","author":"AJ Harmar","year":"2004","unstructured":"Harmar AJ, Sheward WJ, Morrison CF, Waser B, Gugger M, Reubi JC: Distribution of the VPAC2 receptor in peripheral tissues of the mouse. Endocrinology. 2004, 145: 1203-1210. 10.1210\/en.2003-1058.","journal-title":"Endocrinology"},{"key":"695_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cne.20168","volume":"475","author":"T Kalamatianos","year":"2004","unstructured":"Kalamatianos T, Kallo I, Piggins HD, Coen CW: Expression of VIP and\/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites. J Comp Neurol. 2004, 475: 19-35. 10.1002\/cne.20168.","journal-title":"J Comp Neurol"},{"key":"695_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb06946.x","volume":"921","author":"JC Reubi","year":"2000","unstructured":"Reubi JC: In vitro evaluation of VIP\/PACAP receptors in healthy and diseased human tissues. Clinical implications. Ann N Y Acad Sci. 2000, 921: 1-25.","journal-title":"Ann N Y Acad Sci"},{"key":"695_CR23","first-page":"3105","volume":"60","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Laderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA: Vasoactive intestinal peptide\/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res. 2000, 60: 3105-3112.","journal-title":"Cancer Res"},{"key":"695_CR24","doi-asserted-by":"publisher","first-page":"8235","DOI":"10.1158\/1078-0432.CCR-04-0939","volume":"10","author":"S Schulz","year":"2004","unstructured":"Schulz S, Rocken C, Mawrin C, Weise W, Hollt V, Schulz S: Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies. Clin Cancer Res. 2004, 10: 8235-8242. 10.1158\/1078-0432.CCR-04-0939.","journal-title":"Clin Cancer Res"},{"key":"695_CR25","first-page":"619","volume":"21","author":"NM Sherwood","year":"2000","unstructured":"Sherwood NM, Krueckl SL, McRory JE: The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)\/glucagon superfamily. Endocr Rev. 2000, 21: 619-670.","journal-title":"Endocr Rev"},{"key":"695_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1741-7015-7-14","volume":"7","author":"C Millino","year":"2009","unstructured":"Millino C, Fanin M, Vettori A, Laveder P, Mostacciuolo ML, Angelini C, Lanfranchi G: Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy. BMC Med. 2009, 7: 14-10.1186\/1741-7015-7-14.","journal-title":"BMC Med"},{"key":"695_CR27","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1172\/JCI46276","volume":"121","author":"F Farooq","year":"2011","unstructured":"Farooq F, Molina FA, Hadwen J, MacKenzie D, Witherspoon L, Osmond M, Holcik M, MacKenzie A: Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway. J Clin Invest. 2011, 121: 3042-3050. 10.1172\/JCI46276.","journal-title":"J Clin Invest"},{"key":"695_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jpeds.2009.01.071","volume":"155","author":"A Araujo","year":"2009","unstructured":"Araujo A, Araujo M, Swoboda KJ: Vascular perfusion abnormalities in infants with spinal muscular atrophy. J Pediatr. 2009, 155: 292-294. 10.1016\/j.jpeds.2009.01.071.","journal-title":"J Pediatr"},{"key":"695_CR29","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1093\/hmg\/ddq300","volume":"19","author":"AK Bevan","year":"2010","unstructured":"Bevan AK, Hutchinson KR, Foust KD, Braun L, McGovern VL, Schmelzer L, Ward JG, Petruska JC, Lucchesi PA, Burghes AH, Kaspar BK: Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum Mol Genet. 2010, 19: 3895-3905. 10.1093\/hmg\/ddq300.","journal-title":"Hum Mol Genet"},{"key":"695_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ana.23582","volume":"72","author":"M Bowerman","year":"2012","unstructured":"Bowerman M, Swoboda KJ, Michalski JP, Wang GS, Reeks C, Beauvais A, Murphy K, Woulfe J, Screaton RA, Scott FW, Kothary R: Glucose metabolism and pancreatic defects in spinal muscular atrophy. Ann Neurol. 2012, 72: 256-268. 10.1002\/ana.23582.","journal-title":"Ann Neurol"},{"key":"695_CR31","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1523\/JNEUROSCI.5775-11.2012","volume":"32","author":"RG Gogliotti","year":"2012","unstructured":"Gogliotti RG, Quinlan KA, Barlow CB, Heier CR, Heckman CJ, Didonato CJ: Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction. J Neurosci. 2012, 32: 3818-3829. 10.1523\/JNEUROSCI.5775-11.2012.","journal-title":"J Neurosci"},{"key":"695_CR32","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1093\/hmg\/ddq330","volume":"19","author":"CR Heier","year":"2010","unstructured":"Heier CR, Satta R, Lutz C, DiDonato CJ: Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum Mol Genet. 2010, 19: 3906-3918. 10.1093\/hmg\/ddq330.","journal-title":"Hum Mol Genet"},{"key":"695_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature10485","volume":"478","author":"Y Hua","year":"2011","unstructured":"Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF, Krainer AR: Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature. 2011, 478: 123-126. 10.1038\/nature10485.","journal-title":"Nature"},{"key":"695_CR34","doi-asserted-by":"publisher","first-page":"8703","DOI":"10.1523\/JNEUROSCI.0204-12.2012","volume":"32","author":"TL Martinez","year":"2012","unstructured":"Martinez TL, Kong L, Wang X, Osborne MA, Crowder ME, Van Meerbeke JP, Xu X, Davis C, Wooley J, Goldhamer DJ: Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy. J Neurosci. 2012, 32: 8703-8715. 10.1523\/JNEUROSCI.0204-12.2012.","journal-title":"J Neurosci"},{"key":"695_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/mus.21654","volume":"42","author":"S Rudnik-Schoneborn","year":"2010","unstructured":"Rudnik-Schoneborn S, Vogelgesang S, Armbrust S, Graul-Neumann L, Fusch C, Zerres K: Digital necroses and vascular thrombosis in severe spinal muscular atrophy. Muscle Nerve. 2010, 42: 144-147. 10.1002\/mus.21654.","journal-title":"Muscle Nerve"},{"key":"695_CR36","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1093\/hmg\/ddq329","volume":"19","author":"M Shababi","year":"2010","unstructured":"Shababi M, Habibi J, Yang HT, Vale SM, Sewell WA, Lorson CL: Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum Mol Genet. 2010, 19: 4059-4071. 10.1093\/hmg\/ddq329.","journal-title":"Hum Mol Genet"},{"key":"695_CR37","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1124\/jpet.106.112276","volume":"320","author":"CQ Pan","year":"2007","unstructured":"Pan CQ, Li F, Tom I, Wang W, Dumas M, Froland W, Yung SL, Li Y, Roczniak S, Claus TH: Engineering novel VPAC2-selective agonists with improved stability and glucose-lowering activity in vivo. J Pharmacol Exp Ther. 2007, 320: 900-906.","journal-title":"J Pharmacol Exp Ther"},{"key":"695_CR38","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2337\/diabetes.51.5.1453","volume":"51","author":"M Tsutsumi","year":"2002","unstructured":"Tsutsumi M, Claus TH, Liang Y, Li Y, Yang L, Zhu J, Dela Cruz F, Peng X, Chen H, Yung SL: A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes. Diabetes 2002, 51: 1453-1460. 10.2337\/diabetes.51.5.1453.","journal-title":"Diabetes"},{"key":"695_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.npep.2012.08.008","volume":"47","author":"V Darsalia","year":"2012","unstructured":"Darsalia V, Mansouri S, Wolbert P, Barde S, Sjoholm A, Patrone C: The specific VPAC2 agonist Bay 55-9837 increases neuronal damage and hemorrhagic transformation after stroke in type 2 diabetic rats. Neuropeptides. 2012, 47: 133-137.","journal-title":"Neuropeptides"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-9-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T19:32:36Z","timestamp":1716406356000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-9-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-9-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,9]]},"assertion":[{"value":"13 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}